Sheryl Ann Abdukahil

INFJ-A

[Critical Care Reviews @CritCareReviews]

Chief Investigator Yaseen Arabi reflects on the #SCREENtrial and what it means for clinicians after presenting the results at #CCRdownunder

[Yaseen Arabi @YaseenarabiYa]

SCREEN trial: electronic sepsis screening reduces mortality among hospitalized patients.
Presented at #CCRdownunder @CriticalCareReviews, published in JAMA
Paper in JAMA: https://t.co/JwaKRDNfa1 
Podcast by JAMA Editors: https://t.co/wPZJC8QgQL
Editorial: https://t.co/eSrgU8JJQs

[Critical Care Reviews @CritCareReviews]

SCREEN Trial

Electronic Early Notification of Sepsis in Hospitalized Ward Patients

Prof Yaseen Arabi presents the results of the SCREEN trial in CCR Down Under, Melbourne.

#CCRdownunder

[JAMA @JAMA_current]

Among hospitalized patients, electronic sepsis screening compared with no screening resulted in lower in-hospital 90-day mortality.

#CCRdownunder @CritCareReviews

https://t.co/bQrrs3AaAY

[Intensive Care Medicine @yourICM]

🦠 Long-term outcomes of #COVID19 pts w acute hypoxemic respiratory failure. Helmet NIV vs usual respiratory support did not decrease 180-day mortality or improve HRQoL. IMV independent predictor of lower HRQoL.
Free to read #FOAMcc #COVIDFOAM @yourICM
🖇️ https://t.co/Z86a1oYcQm

[Yaseen Arabi @YaseenarabiYa]

"The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure" #MyOAarticle

Access the article here: https://t.co/4UpiFmMLiD

[Yaseen Arabi @YaseenarabiYa]

Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: Helmet-COVID RCT ⁦⁦@yourICM⁩

https://t.co/427HX1m5Up

[Sheryl Ann Abdukahil @sheabdkhl]

It was a blast! #BASICRESEARCHCOORDINATION

[A Prof Rachael Parke 💙 @RachaelParke]

#BASICRESEARCHCOORDINATION finished up with an OSCE competition. And we all know how competitive research coordinators can be! Same the world over including in Jeddah. Thanks for a great course @YaseenarabiYa @sheabdkhl @SaudiCCSociety @minaNahool

[JAMA @JAMA_current]

Helmet noninvasive ventilation did not significantly reduce 28-day mortality vs usual respiratory support among patients with acute hypoxemic respiratory failure due to #COVID19 #pneumonia. https://t.co/LCuuY9UqZA #Research

[JAMA @JAMA_current]

In this trial, in patients with acute hypoxemic respiratory failure from #COVID19, prone positioning, compared with usual care without prone positioning, did not significantly reduce endotracheal intubation at 30 days. https://t.co/1RyYRtcrYj

[SarahCulgin @SarahCulgin]

Extremely proud to have been part of the incredible team leading this trial from our Canadian and Saudi Arabian Methods Centres.

@AlhazzaniW @ZDuhailib @KenParhar @AlbertaPHdoc @YaseenarabiYa @sheabdkhl

#evidencebasedmedicine #COVID19 #research #criticalcare @GUIDEgroup_CA

[Mega-ROX @MegaROXtrial]

Here is an infographic from @DogICUma explaining the #MegaROX trial. Feel free to drop any questions 👇

[Sheryl Ann Abdukahil @sheabdkhl]

@Lefwee_93 What is the meaning of this??

[remap-cap @remap_cap]

On the recommendation of the data safety and monitoring board, @REMAP_CAP is declaring efficacy of #tocilizumab with an OR of 1.87 for benefit on a combination of survival and length of time patients received organ support in ICU, compared with standard care [...]

[Dr. Jennifer Kwan @jkwan_md]

“Swiss cheese model” for #COVID19 prevention - no layer alone is sufficient, but ALL layers together will limit leaks through the holes!🧀😋

[The Lancet @TheLancet]

Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet https://t.co/pPNCJ3nO8n

[Yaseen Arabi @YaseenarabiYa]

I encourage Saudi ICUs to join #UNITECOVID19 to better understand the burden of #COVID19 admissions & outcomes in our ICUs and across the world @esicm ⁦@JanJDeWaele⁩ https://t.co/wpELz4ID71

[AFP News Agency @AFP]

#BREAKING WHO suspends trial of hydroxychloroquine as COVID-19 treatment over safety concerns

[Charlie M. Wray, DO, MS @WrayCharles]

Dear Medical Journals,

For the love of all that is holy, can we just have one universal format for initial submissions!? I promise to jump through all the other little hoops once it's accepted. Please...

Love,
Charlie

[David Juurlink @DavidJuurlink]

“We gave sick people a drug and some of them got better.” - PubMed now, apparently.